Senior Lecturer in Policing Studies, Charles Sturt University I am an interdisciplinary teaching researcher currently focusing on crime, policing, and security issues at Charles Sturt University, Australia, with previous experience as a police practitioner.
Medical Director, Kimberley Aboriginal Medical Services, Indigenous Knowledge Dr Lorraine Anderson is an Aboriginal doctor and Medical Director at Kimberley Aboriginal Medical Services in Broome. Lorraine gained her primary degree in Medicine at The University of Auckland in New Zealand, followed by post graduate qualifications Master of Public Health and Tropical Medicine (James Cook University), Child Health, Palliative Medicine and PG Dip General Practice.
Research Officer in School of Health Sciences, Bangor University Health services, social care, policy and qualitative methods researcher. Interested in a wide range of health and social care services, policy and health systems research.
Principal Clinical Research Scientist, KEMRI Wellcome Trust Research Programme Linnet Ongeri (MBChB, M.Med(Psych), PhD) is a psychiatrist and a scientist. Her expertise includes clinical research and development, public health and epidemiology, policy formulation, data analysis, and monitoring and evaluation. Her research interest is in designing and implementing appropriate cultural and regional research models that integrate mental health in primary health care. She is a member of the Taskforce on Mental Health in Kenya and collaborates with and guides the Ministry of Health Technical Working Group at the national and county level. She is also an investigator on several studies that include: 1) testing strategies for integrating non-specialist delivery of evidence-based interventions for depression and/or trauma-disorder with primary care services at public sector hospitals; and 2) analysing neuropsychiatric genetics of African populations. The latter is funded by the Broad Institute of MIT and Harvard. She has been a co-investigator in other studies exploring psychotherapy for HIV+ women affected by gender based violence, prevalence of post-partum depression among women attending selected maternal and child health clinics, and mental health assessment in primary care facilities.
Lecturer in Property Economics, Queensland University of Technology Lyndall Bryant has been on the academic staff QUT’s School of Built Environment and Civil Engineering as a lecturer in Property Economics since 2009. Prior to joining academia, Dr Bryant had almost 20 years working in the housing development, corporate property and finance sectors, holding management positions in some of Australia’s leading property development companies and consultancy firms including Stockland, Mirvac, Macquarie Bank and Ernst & Young. She specialises in property development, property finance and economic sustainability (such as, feasibility analysis, finance, options analysis, and barriers to supply). She has written and presented research papers and reports on various property development, infrastructure and housing affordability matters as well as other financing related policy issues. These works had been used by a range of stakeholders including national corporations, government agencies and policy makers at all levels of government. Dr Bryant is a Registered Valuer in Queensland as well as a Certified Practicing Valuer under the provisions of the Australian Property Institute. She sits on the national board of EnviroDevelopment, an independent, national sustainability rating tool; is a board member of the Pacific Rim Real Estate Society and serves on a number of University and industry committees. She is a regular presenter in the Urban Development of Australia’s (Qld) education series as well as at other industry events and training forums. Dr Bryant holds postgraduate qualifications (GradDip in Advanced Finance and Investments) from the Securities Institute of Australia (FINSIA) and her PhD is from Queensland University of Technology.
Senior Lecturer and Group Leader, Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University Dr May leads the Cardiac GPCR Biology laboratory at Monash Institute of Pharmaceutical Sciences (MIPS), Monash University. Dr May uses her molecular pharmacology expertise to apply new and innovative drug discovery approaches to facilitate the development of safe and effective therapeutics. She employs multidisciplinary methods to achieve these research goals, including artificial intelligence, computational biology, and molecular and analytical pharmacology. Dr. May has secured significant competitive funding, which has led to impactful publications in Nature, Cell, Nature Machine Intelligence, Nature Communications, and Proc. Natl. Acad. Sci. USA. Dr May is committed to improving health outcomes as advisory member for the Australian Cardiovascular Alliance Drug Discovery Flagship and inaugural Chair of the Monash Institute of Pharmaceutical Sciences Climate Health Initiative. Dr May is an advocate for diversity in science, co-founder and past chair of Her Research Matters (2021 Monash University Vice-Chancellor’s Award for Excellence in Diversity and Inclusion) and a member of the 2019 International Women’s Forum (IWFA) Emerging Leaders Cohort.